A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

NCT07459556 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

SAR

Interventions

BIOLOGICAL: Stapokibart

Sponsor

Chengdu Kangnuoxing Biopharma,Inc.